The Developmental Therapeutics Program at Texas Children's Cancer Center focuses on the development and creation of new therapies for newly diagnosed and relapses in pediatric cancer. We work closely with the Pediatric Center for Personal Cancer Genomics and Therapeutics to identify personalized, unique treatment options. Physicians and families may contact the Developmental Therapeutics Program by calling 832-824-4570 or 1-800-226-2379. To learn more, visit txch.org/cancer-center/developmental-therapeutics-program.

Nongestational choriocarcinoma is an exceedingly rare very aggressive germ cell neoplasm accounting for less than 1% of primitive germ cell tumors.
It can occur in pure form or as a component of a mixed germ cell tumor. Nongestational choriocarcinoma has been found to be resistant to single agent chemotherapy and has a worse prognosis than gestational choriocarcinoma.

Jack Rolle shares his journey with us after surviving Childhood Mixed Cell Germinoma Brain Cancer from Winston Salem, North Carolina. During this video you will hear Jack perform his hit single, "Day I Die".

Immature teratoma comprises approximately 3% of ovarian teratomas and 15-20% of all primitive germ cell tumors of the ovary. It usually presents as a pelvic mass in children and adolescents. 
About 10% of cases are bilateral.

Classification of ovarian tumors with some important clinical and pathological points
Correction :- at 18:37 :- granulosa cell tumor causes homosexual precocious puberty in female children